Ammon-Treiber Susanne, Grecksch Gisela, Angelidis Charalampos, Vezyraki Patra, Höllt Volker, Becker Axel
Institute of Pharmacology and Toxicology, Otto-von-Guericke University Magdeburg, Leipziger Street 44, 39120, Magdeburg, Germany.
Naunyn Schmiedebergs Arch Pharmacol. 2007 Apr;375(2):115-21. doi: 10.1007/s00210-007-0143-0. Epub 2007 Feb 28.
Kindling induced by the convulsant pentylenetetrazol (PTZ) is an accepted model of primary generalized epilepsy. Because seizures represent a strong distressing stimulus, stress-induced proteins such as heat shock proteins might counteract the pathology of increased neuronal excitation. Therefore, the aim of the present study was to determine whether PTZ kindling outcome parameters are influenced by heat shock protein 70 (Hsp70) overexpression in Hsp70 transgenic mice as compared to the respective wild-type mice. Kindling was performed by nine intraperitoneal injections of PTZ (ED(16) for induction of clonic-tonic seizures, every 48 h); control animals received saline instead of PTZ. Seven days after the final injection, all mice received a PTZ challenge dose. Outcome parameters included evaluation of seizure stages and overall survival rates. In addition, histopathological findings such as cell number in hippocampal subfields CA1 and CA3 were determined. The onset of the highest convulsion stage was delayed in Hsp70 transgenic mice as compared to wild-type mice, and overall survival during kindling was improved in Hsp70 transgenic mice as compared to wild-type mice. In addition, a challenge dose after termination of kindling produced less severe seizures in Hsp70 transgenic mice than in wild-type mice. PTZ kindling did not result in significant subsequent neuronal cell loss in CA1 or CA3 neither in wild-type mice nor in the Hsp70 transgenic mice. The results of the present experiments clearly demonstrate that overexpression of Hsp70 exerts protective effects regarding seizure severity and overall survival during PTZ kindling. In addition, the decreased seizure severity in Hsp70 transgenic mice after a challenge dose suggests an interference of Hsp70 with the developmental component of kindling.
惊厥剂戊四氮(PTZ)诱导的点燃是公认的原发性全身性癫痫模型。由于癫痫发作是一种强烈的痛苦刺激,应激诱导蛋白如热休克蛋白可能会对抗神经元兴奋性增加的病理过程。因此,本研究的目的是确定与相应的野生型小鼠相比,热休克蛋白70(Hsp70)转基因小鼠中Hsp70的过表达是否会影响PTZ点燃的结果参数。通过腹腔注射九次PTZ(诱导阵挛 - 强直发作的ED(16),每48小时一次)进行点燃;对照动物接受生理盐水而非PTZ。末次注射后7天,所有小鼠接受PTZ激发剂量。结果参数包括癫痫发作阶段的评估和总体存活率。此外,还确定了组织病理学结果,如海马亚区CA1和CA3中的细胞数量。与野生型小鼠相比,Hsp70转基因小鼠中最高惊厥阶段的发作延迟,并且与野生型小鼠相比,Hsp70转基因小鼠在点燃过程中的总体存活率提高。此外,点燃终止后的激发剂量在Hsp70转基因小鼠中产生的癫痫发作比野生型小鼠轻。PTZ点燃在野生型小鼠和Hsp70转基因小鼠的CA1或CA3中均未导致明显的后续神经元细胞丢失。本实验结果清楚地表明,Hsp70的过表达在PTZ点燃期间对癫痫发作严重程度和总体存活率具有保护作用。此外,Hsp70转基因小鼠在接受激发剂量后癫痫发作严重程度降低,这表明Hsp70干扰了点燃的发育成分。